ARTURO MD MOLINA
CIK 1398940 · Chief Medical Officer · last filed 2026-03-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$14.60M
Companies
4
Total Filings
42
Lifetime Open-Market Net
-$8.79M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTGX | Chief Medical Officer | 99,115 | $146.49 | $14.52M | -$8.84M | 15 | 2026-03-27 |
| Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Director | 0 | $20.01 | $0 | $0 | 3 | 2022-10-14 |
| STRO | Chief Medical Officer | 3,774 | $20.82 | $78.6K | $50.0K | 11 | 2022-03-07 |
| Cougar Biotechnology, Inc. (CGRB) Delisted | Chief Medical Officer | — | — | — | $0 | 2 | 2009-07-07 |
Recent Filings · Page 3 of 5
42 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-11-19 | PTGX | Sell (S) | −1,906 | -$78.1K | EDGAR |
| 2024-01-18 | PTGX | Tax (F) | −427 | -$10.5K | EDGAR |
| 2024-01-04 | PTGX | Mixed | +24,402 | -$30.0K | EDGAR |
| 2023-01-18 | PTGX | Grant (A) | +3,125 | $0 | EDGAR |
| 2022-11-17 | PTGX | Grant (A) | +21,250 | $0 | EDGAR |
| 2022-10-14 | Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Mixed | −10,000 | $0 | EDGAR |
| 2022-06-09 | Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Grant (A) | +4,500 | $0 | EDGAR |
| 2022-03-07 | STRO | Mixed | +8,145 | -$35.6K | EDGAR |
| 2022-02-01 | STRO | Mixed | +3,099 | -$22.3K | EDGAR |
| 2022-01-13 | Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Grant (A) | +5,500 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.